Kaiyue Su

机构：Sichuan University, Henan University of Technology, State Key Laboratory of Biotherapy

发表论文 9 篇 · 总被引 183 次 · h-index 7

代表论文

• Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition (2023 · Journal of Medicinal Chemistry · 被引 89)
• Design, Synthesis, and Biological Evaluation of Novel P2X7 Receptor Antagonists for the Treatment of Septic Acute Kidney Injury (2023 · Journal of Medicinal Chemistry · 被引 22)
• Novel Isoalantolactone-Based Derivatives as Potent NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization (2024 · Journal of Medicinal Chemistry · 被引 18)
• Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis (2023 · Journal of Medicinal Chemistry · 被引 18)
• Mechanisms and therapeutic strategies for NLRP3 degradation via post-translational modifications in ubiquitin-proteasome and autophagy lysosomal pathway (2025 · European Journal of Medicinal Chemistry · 被引 10)
• Valtrate alleviates inflammation by targeting USP9X to enhance NLRP3 degradation (2025 · Phytomedicine · 被引 8)